{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 150994, "items": [{"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T23:35:50Z", "timestamp": 1574292950875}, "reference-count": 358, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 7, 1]], "date-time": "2007-07-01T00:00:00Z", "timestamp": 1183248000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacology & Therapeutics"], "published-print": {"date-parts": [[2007, 7]]}, "DOI": "10.1016/j.pharmthera.2007.04.007", "type": "journal-article", "created": {"date-parts": [[2007, 5, 15]], "date-time": "2007-05-15T13:30:32Z", "timestamp": 1179235832000}, "page": "116-147", "source": "Crossref", "is-referenced-by-count": 152, "title": ["Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs"], "prefix": "10.1016", "volume": "115", "author": [{"given": "Agnieszka", "family": "Palucha", "sequence": "first", "affiliation": []}, {"given": "Andrzej", "family": "Pilc", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacology & Therapeutics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0163725807000848?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0163725807000848?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 28]], "date-time": "2019-04-28T00:36:29Z", "timestamp": 1556411789000}, "score": 83.78942, "issued": {"date-parts": [[2007, 7]]}, "references-count": 358, "journal-issue": {"published-print": {"date-parts": [[2007, 7]]}, "issue": "1"}, "alternative-id": ["S0163725807000848"], "URL": "http://dx.doi.org/10.1016/j.pharmthera.2007.04.007", "ISSN": ["0163-7258"], "issn-type": [{"value": "0163-7258", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:19:32Z", "timestamp": 1574245172953}, "reference-count": 90, "publisher": "Informa Healthcare", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Expert Opinion on Investigational Drugs"], "published-print": {"date-parts": [[2006, 12]]}, "DOI": "10.1517/13543784.15.12.1545", "type": "journal-article", "created": {"date-parts": [[2006, 11, 16]], "date-time": "2006-11-16T02:10:42Z", "timestamp": 1163643042000}, "page": "1545-1553", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Are compounds acting at metabotropic glutamate receptors the answer to treating depression?"], "prefix": "10.1517", "volume": "15", "author": [{"given": "Agnieszka", "family": "Palucha", "sequence": "first", "affiliation": [{"name": "Institute of Pharmacology, Polish Academy of Sciences, Smetna 12 Street, 31343 Krak\u00f3w, Poland."}]}], "member": "3197", "published-online": {"date-parts": [[2006, 11, 15]]}, "reference": [{"key": "CIT0001", "DOI": "10.1001/jama.285.5.535", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1111/j.1468-1331.2005.01202.x", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1097/00005053-199903000-00007", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "author": "M", "year": "1987", "volume-title": "Molecular neurobiology of the mammalian brain"}, {"key": "CIT0005", "DOI": "10.1146/annurev.pa.29.040189.002301", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1007/3-540-28082-0_10", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1126/science.1329206", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1146/annurev.pharmtox.37.1.205", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1176/ajp.150.11.1731", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1016/j.pscychresns.2005.12.004", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1001/archpsyc.61.7.705", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1016/j.metabol.2005.01.008", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1146/annurev.neuro.22.1.105", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1016/S0306-4522(97)00303-5", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1016/S0165-3806(97)00079-5", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1016/0306-4522(95)00259-L", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "author": "HALPAIN", "volume": "18", "first-page": "9835", "year": "1998", "journal-title": "J. Neurosci", "DOI": "10.1523/JNEUROSCI.18-23-09835.1998", "doi-asserted-by": "crossref"}, {"key": "CIT0018", "DOI": "10.1002/hipo.20160", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1016/j.biopsych.2004.02.033", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1523/JNEUROSCI.5033-04.2005", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "DOI": "10.1211/0022357001774057", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "DOI": "10.1007/BF00842595", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1016/S0014-2999(97)01589-6", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1016/0922-4106(93)90199-J", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "DOI": "10.1016/S0306-4522(03)00380-4", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "DOI": "10.1016/S0028-3908(00)00090-3", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1016/S0014-2999(99)00330-1", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "author": "DANYSZ", "volume": "8", "first-page": "261", "year": "1996", "journal-title": "Drug News Perspect"}, {"key": "CIT0029", "DOI": "10.1016/S0006-3223(99)00230-9", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "unstructured": "NATIONAL INSTITUTE OFMENTAL HEALTH: A double-blind randomized placebo-controlled trial of felbamate in treatment resistant bipolar depression. (Year initiated: 2002):Clinical trial identifier NCT00034229."}, {"key": "CIT0031", "DOI": "10.1176/appi.ajp.161.1.171", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "DOI": "10.1176/appi.ajp.161.11.2132", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "DOI": "10.1016/j.biopsych.2004.11.023", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "DOI": "10.1016/j.bcp.2005.12.022", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "author": "SCHOEPP", "volume": "299", "first-page": "12", "year": "2001", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "CIT0036", "DOI": "10.1016/S0301-0082(98)00095-1", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "DOI": "10.2174/1568026054750236", "doi-asserted-by": "publisher"}, {"key": "CIT0038", "DOI": "10.1002/cne.903550310", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.1016/0304-3940(93)90227-C", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1016/S0028-3908(99)00082-9", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "DOI": "10.1021/jm025570j", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "DOI": "10.1038/sj.bjp.0703923", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "DOI": "10.1016/j.pbb.2005.06.015", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "DOI": "10.1016/0091-3057(92)90444-K", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "author": "BELOZERTSEVA", "year": "2006", "journal-title": "Eur. Neuropsychopharmacol"}, {"key": "CIT0046", "DOI": "10.1124/jpet.106.103143", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.1016/S0163-7258(97)00004-1", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "DOI": "10.1016/S0028-3908(02)00082-5", "doi-asserted-by": "publisher"}, {"key": "CIT0049", "DOI": "10.1007/s00726-001-0131-5", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "DOI": "10.1038/sj.bjp.0703904", "doi-asserted-by": "publisher"}, {"key": "CIT0051", "author": "AWAD", "volume": "20", "first-page": "7871", "year": "2000", "journal-title": "J. Neurosci.", "DOI": "10.1523/JNEUROSCI.20-21-07871.2000", "doi-asserted-by": "crossref"}, {"key": "CIT0052", "DOI": "10.1016/S0306-4522(01)00297-4", "doi-asserted-by": "publisher"}, {"key": "CIT0053", "DOI": "10.1016/S0028-3908(99)00223-3", "doi-asserted-by": "publisher"}, {"key": "CIT0054", "DOI": "10.1016/S0028-3908(01)00091-0", "doi-asserted-by": "publisher"}, {"key": "CIT0055", "DOI": "10.1016/S0028-3908(03)00048-0", "doi-asserted-by": "publisher"}, {"key": "CIT0056", "author": "PALUCHA", "volume": "54", "first-page": "581", "year": "2002", "journal-title": "Pol. J. Pharmacol."}, {"key": "CIT0057", "DOI": "10.1016/S0014-2999(98)00169-1", "doi-asserted-by": "publisher"}, {"key": "CIT0058", "DOI": "10.1016/S0014-2999(99)00757-8", "doi-asserted-by": "publisher"}, {"key": "CIT0059", "DOI": "10.1016/S0028-3908(02)00062-X", "doi-asserted-by": "publisher"}, {"key": "CIT0060", "DOI": "10.1124/jpet.105.089839", "doi-asserted-by": "publisher"}, {"key": "CIT0061", "author": "PECKNOLD", "volume": "27", "first-page": "119", "year": "1980", "journal-title": "Curr. Ther. Res"}, {"key": "CIT0062", "author": "PECKNOLD", "volume": "2", "first-page": "129", "year": "1980", "journal-title": "J. Clin. Psychopharmacol"}, {"key": "CIT0063", "author": "LAPIERRE", "volume": "31", "first-page": "95", "year": "1982", "journal-title": "Curr. Ther. Res"}, {"key": "CIT0064", "author": "FRIEDMANN", "volume": "27", "first-page": "144", "year": "1980", "journal-title": "Curr. Ther. Res"}, {"key": "CIT0065", "DOI": "10.1002/cne.903350209", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "DOI": "10.1016/0306-4522(93)90485-X", "doi-asserted-by": "publisher"}, {"key": "CIT0067", "DOI": "10.1016/j.neuropharm.2006.03.014", "doi-asserted-by": "publisher"}, {"key": "CIT0068", "DOI": "10.1038/nrd1630", "doi-asserted-by": "publisher"}, {"key": "CIT0069", "DOI": "10.1016/S0028-3908(99)00066-0", "doi-asserted-by": "publisher"}, {"key": "CIT0070", "DOI": "10.1016/j.neuropharm.2003.10.009", "doi-asserted-by": "publisher"}, {"key": "CIT0071", "DOI": "10.1007/s00213-006-0390-7", "doi-asserted-by": "publisher"}, {"key": "CIT0072", "DOI": "10.1016/j.bbrc.2004.01.073", "doi-asserted-by": "publisher"}, {"key": "CIT0073", "DOI": "10.1016/j.bmc.2006.01.060", "doi-asserted-by": "publisher"}, {"key": "CIT0074", "DOI": "10.1016/j.neulet.2004.12.021", "doi-asserted-by": "publisher"}, {"key": "CIT0075", "DOI": "10.1016/j.brainres.2005.02.032", "doi-asserted-by": "publisher"}, {"key": "CIT0076", "DOI": "10.1016/j.neulet.2005.09.058", "doi-asserted-by": "publisher"}, {"key": "CIT0077", "author": "GASPARINI", "volume": "289", "first-page": "1678", "year": "1999", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "CIT0078", "DOI": "10.1016/j.neuropharm.2003.09.006", "doi-asserted-by": "publisher"}, {"key": "CIT0079", "DOI": "10.1211/0022357021778862", "doi-asserted-by": "publisher"}, {"key": "CIT0080", "author": "KLAK", "year": "2006", "journal-title": "Amino Acids"}, {"key": "CIT0081", "DOI": "10.1046/j.1460-9568.2003.02667.x", "doi-asserted-by": "publisher"}, {"key": "CIT0082", "DOI": "10.1111/j.1460-9568.2005.04210.x", "doi-asserted-by": "publisher"}, {"key": "CIT0083", "DOI": "10.1073/pnas.0508063102", "doi-asserted-by": "publisher"}, {"key": "CIT0084", "DOI": "10.1016/0014-2999(87)90812-0", "doi-asserted-by": "publisher"}, {"key": "CIT0085", "DOI": "10.1007/BF00432027", "doi-asserted-by": "publisher"}, {"key": "CIT0086", "DOI": "10.1007/s002130050749", "doi-asserted-by": "publisher"}, {"key": "CIT0087", "DOI": "10.1016/0006-8993(92)90459-M", "doi-asserted-by": "publisher"}, {"key": "CIT0088", "DOI": "10.1172/JCI115086", "doi-asserted-by": "publisher"}, {"key": "CIT0089", "DOI": "10.1016/0014-2999(93)90550-2", "doi-asserted-by": "publisher"}, {"key": "CIT0090", "DOI": "10.1046/j.1471-4159.2000.0750889.x", "doi-asserted-by": "publisher"}], "container-title": ["Expert Opinion on Investigational Drugs"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.1517/13543784.15.12.1545", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 6]], "date-time": "2018-09-06T16:30:19Z", "timestamp": 1536251419000}, "score": 44.305862, "issued": {"date-parts": [[2006, 11, 15]]}, "references-count": 90, "journal-issue": {"published-online": {"date-parts": [[2006, 11, 15]]}, "published-print": {"date-parts": [[2006, 12]]}, "issue": "12"}, "alternative-id": ["10.1517/13543784.15.12.1545"], "URL": "http://dx.doi.org/10.1517/13543784.15.12.1545", "relation": {"cites": []}, "ISSN": ["1354-3784", "1744-7658"], "issn-type": [{"value": "1354-3784", "type": "print"}, {"value": "1744-7658", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T23:33:14Z", "timestamp": 1575156794536}, "reference-count": 54, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3793, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1471-4159.2005.03141.x", "type": "journal-article", "created": {"date-parts": [[2005, 6, 19]], "date-time": "2005-06-19T19:58:21Z", "timestamp": 1119211101000}, "page": "1345-1352", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of \u03b2-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands"], "prefix": "10.1111", "volume": "93", "author": [{"given": "F.", "family": "Matrisciano", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Scaccianoce", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Del Bianco", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Panaccione", "sequence": "additional", "affiliation": []}, {"given": "A. M.", "family": "Canudas", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Battaglia", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Riozzi", "sequence": "additional", "affiliation": []}, {"given": "R. T.", "family": "Ngomba", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Molinaro", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Tatarelli", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Melchiorri", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Nicoletti", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2005, 4, 13]]}, "reference": [{"key": "10.1111/j.1471-4159.2005.03141.x-BIB52|cit2", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1097/00124509-200209000-00005", "article-title": "Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain", "volume": "18", "author": "Angelucci", "year": "2002", "journal-title": "J. ECT"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB2|cit3", "doi-asserted-by": "crossref", "first-page": "378", "DOI": "10.1016/S0166-2236(96)10037-0", "article-title": "Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists", "volume": "19", "author": "Artigas", "year": "1996", "journal-title": "Trends Neurosci."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB45|cit4", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1016/0028-3908(83)90186-7", "article-title": "On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors", "volume": "22", "author": "Barbaccia", "year": "1983", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB34|cit5", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/0014-2999(88)90089-1", "article-title": "Rapid down regulation of beta-adrenoreceptors by co-administration of desipramine and fluoxetine", "volume": "154", "author": "Baron", "year": "1988", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB35|cit6", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/BF02244958", "article-title": "Fluoxetine: a review of receptor and functional effects and their clinical implications", "volume": "107", "author": "Beasley", "year": "1992", "journal-title": "Psychopharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB23|cit7", "first-page": "800", "article-title": "Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo", "volume": "294", "author": "Bond", "year": "2000", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB26|cit8", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1016/0003-2697(76)90527-3", "article-title": "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding", "volume": "72", "author": "Bradford", "year": "1976", "journal-title": "Anal. Biochem."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB15|cit9", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.1097/00004647-200109000-00001", "article-title": "Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs", "volume": "21", "author": "Bruno", "year": "2001", "journal-title": "J. Cereb. Blood Flow Metab."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB38|cit10", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1007/BF00735896", "article-title": "Decreased beta-adrenergic receptors in rat after chronic administration of the selective serotonin uptake inhibitor fluoxetine", "volume": "94", "author": "Byerley", "year": "1988", "journal-title": "Psychopharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB7|cit11", "doi-asserted-by": "crossref", "first-page": "2847", "DOI": "10.1111/j.1460-9568.2004.03378.x", "article-title": "Distinct properties of presynaptic group II and III metabotropic glutamate receptor-mediated inhibition of perforant pathway-CA1 EPSCs", "volume": "19", "author": "Capogna", "year": "2004", "journal-title": "Eur. J. Neurosci."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB44|cit12", "doi-asserted-by": "crossref", "first-page": "378", "DOI": "10.1016/S0006-8993(00)03067-5", "article-title": "Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum", "volume": "887", "author": "Cartmell", "year": "2000", "journal-title": "Brain Res."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB20|cit13", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1016/j.neuropharm.2003.10.009", "article-title": "MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity", "volume": "46", "author": "Chaki", "year": "2004", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB16|cit14", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1002/(SICI)1098-1136(199909)27:3<275::AID-GLIA9>3.0.CO;2-0", "article-title": "Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes", "volume": "27", "author": "Ciccarelli", "year": "1999", "journal-title": "Glia"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB43|cit15", "doi-asserted-by": "crossref", "first-page": "2409", "DOI": "10.1046/j.1460-9568.2003.02667.x", "article-title": "Antidepressant and anxiolytic like effects in mice lacking the group III metabotropic glutamate receptor mGluR7", "volume": "17", "author": "Cryan", "year": "2003", "journal-title": "Eur. J. Neurosci."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB40|cit16", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1016/S0197-0186(02)00073-6", "article-title": "Mechanisms of metabotropic glutamate receptor desensitization: role in the patterning of effector enzyme activation", "volume": "41", "author": "Dale", "year": "2002", "journal-title": "Neurochem. Int."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB5|cit17", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1016/S0165-6147(00)01635-7", "article-title": "Molecular determinants of metabotropic glutamate receptor signaling", "volume": "22", "author": "De Blasi", "year": "2001", "journal-title": "Trends Pharmacol. Sci."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB53|cit18", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1016/S0028-3908(03)00198-9", "article-title": "Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain", "volume": "45", "author": "Dias", "year": "2003", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB10|cit19", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1192/bjp.164.3.365", "article-title": "Glucocorticoids and the genesis of depressive illness. A psychobiological model", "volume": "164", "author": "Dinan", "year": "1994", "journal-title": "Br. J. Psychiatry"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB25|cit20", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/0160-5402(87)90005-2", "article-title": "Quantitative assessment of central beta1- and beta2-adrenoreceptor regulation using CGP 20712A", "volume": "18", "author": "Dooley", "year": "1987", "journal-title": "J. Pharmacol. Meth."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB27|cit21", "first-page": "1699", "article-title": "Neuroanatomical specificity and dose dependence in the time course of imipramine-induced beta-adrenergic receptor down-regulation in rat brain", "volume": "271", "author": "Duncan", "year": "1994", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB42|cit22", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/0006-8993(94)90857-5", "article-title": "(2S,1\u2032R,2\u2032R,3\u2032R)-2-(2,3-dicarboxycyclopropyl) glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices", "volume": "659", "author": "Genazzani", "year": "1994", "journal-title": "Brain Res."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB18|cit23", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1016/S0091-3057(02)00844-4", "article-title": "Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors", "volume": "73", "author": "Gewirtz", "year": "2002", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB36|cit24", "doi-asserted-by": "crossref", "first-page": "2262", "DOI": "10.1046/j.1471-4159.1994.62062262.x", "article-title": "5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination", "volume": "62", "author": "Goodnough", "year": "1994", "journal-title": "J. Neurochem."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB24|cit25", "doi-asserted-by": "crossref", "first-page": "1213", "DOI": "10.1007/s007020070035", "article-title": "Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression", "volume": "107", "author": "Harkin", "year": "2000", "journal-title": "J. Neural Transm."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB8|cit26", "doi-asserted-by": "crossref", "first-page": "1866", "DOI": "10.1126/science.300.5627.1866", "article-title": "Psychiatric drugs. Excited by glutamate", "volume": "300", "author": "Holden", "year": "2003", "journal-title": "Science"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB11|cit27", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1210/edrv-17-2-187", "article-title": "Antidepressants and hypothalamic-pituitary-adrenocortical regulation", "volume": "17", "author": "Holsboer", "year": "1996", "journal-title": "Endocr. Rev."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB6|cit28", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1016/0006-8993(91)91269-7", "article-title": "Tricyclic antidepressants inhibit Ca2+-activated K+-efflux in cultured spinal cord neurons", "volume": "545", "author": "Kamatchi", "year": "1991", "journal-title": "Brain Res."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB46|cit29", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0028-3908(97)00191-3", "article-title": "LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors", "volume": "37", "author": "Kingston", "year": "1998", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB48|cit30", "doi-asserted-by": "crossref", "first-page": "1831", "DOI": "10.1016/S0028-3908(99)00066-0", "article-title": "Potential anti-anxiety, anti-addictive effects of LY354740, a selective group II glutamate metabotropic receptor agonist in animal models", "volume": "38", "author": "Klodzinska", "year": "1999", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB50|cit31", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1016/0306-4522(94)00550-O", "article-title": "Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock", "volume": "65", "author": "Lindefors", "year": "1995", "journal-title": "Neuroscience"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB49|cit32", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1017/S1461145703003729", "article-title": "Desipramine treatment reduces the long-term behavioural and neurochemical sequelae of early-life maternal separation", "volume": "6", "author": "MacQueen", "year": "2003", "journal-title": "Int. J. Neuropsychopharmacol."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB32|cit33", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/0014-2999(80)90152-1", "article-title": "Differential effects of antidepressant treatment on brain monoaminergic receptors", "volume": "61", "author": "Maggi", "year": "1980", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB54|cit34", "doi-asserted-by": "crossref", "first-page": "9104", "DOI": "10.1523/JNEUROSCI.20-24-09104.2000", "article-title": "Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus", "volume": "24", "author": "Malberg", "year": "2000", "journal-title": "J. Neurosci."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB1|cit35", "first-page": "199", "article-title": "Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies", "volume": "27", "author": "Manji", "year": "1991", "journal-title": "Psychopharmacol. Bull."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB13|cit36", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1038/sj.mp.4000811", "article-title": "Neuroplasticity and cellular resilience in mood disorders", "volume": "5", "author": "Manji", "year": "2000", "journal-title": "Mol. Psych."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB14|cit37", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1038/87865", "article-title": "The cellular neurobiology of depression", "volume": "7", "author": "Manji", "year": "2001", "journal-title": "Nat. Med."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB17|cit38", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1046/j.1471-4159.2001.00056.x", "article-title": "Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction", "volume": "76", "author": "Matarredona", "year": "2001", "journal-title": "J. Neurochem."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB4|cit39", "doi-asserted-by": "crossref", "first-page": "1008", "DOI": "10.1016/S0028-3908(02)00057-6", "article-title": "Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus", "volume": "42", "author": "Matrisciano", "year": "2002", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB21|cit40", "doi-asserted-by": "crossref", "first-page": "1027", "DOI": "10.1021/jm980616n", "article-title": "Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0.]hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors", "volume": "42", "author": "Monn", "year": "1999", "journal-title": "J. Med. Chem."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB51|cit41", "doi-asserted-by": "crossref", "first-page": "7539", "DOI": "10.1523/JNEUROSCI.15-11-07539.1995", "article-title": "Regulation of BDNF and trkB mRNA in rat brain by chronic electoconvulsive seizure and antidepressant drug treatments", "volume": "15", "author": "Nibuya", "year": "1995", "journal-title": "J. Neurosci."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB41|cit42", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1016/0922-4106(93)90111-L", "article-title": "(2S,1\u2032R,2\u2032R,3\u2032R)-2-(2,3-dicarboxycyclopropyl) glycine enhances quisqualate-stimulated inositol phospholipid hydrolysis in hippocampal slices", "volume": "15", "author": "Nicoletti", "year": "1993", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB37|cit43", "doi-asserted-by": "crossref", "first-page": "543", "DOI": "10.1007/BF02245579", "article-title": "Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments", "volume": "115", "author": "Palvimaki", "year": "1994", "journal-title": "Psychopharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB12|cit44", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1016/S0006-3223(00)01088-X", "article-title": "Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment", "volume": "49", "author": "Pariante", "year": "2001", "journal-title": "Biol. Psychiatry"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB39|cit45", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1159/000077739", "article-title": "Drug-induced depression: a systematic review to inform clinical practice", "volume": "73", "author": "Patten", "year": "2004", "journal-title": "Psychother. Psychosom."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB47|cit46", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1016/S0028-3908(02)00082-5", "article-title": "Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats", "volume": "43", "author": "Pilc", "year": "2002", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB3|cit47", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1016/S0893-133X(01)00256-1", "article-title": "The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors", "volume": "25", "author": "Popoli", "year": "2001", "journal-title": "Neuropsychopharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB31|cit48", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/0028-3908(83)90191-0", "article-title": "Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotrasmitter interactions", "volume": "22", "author": "Racagni", "year": "1983", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB9|cit49", "doi-asserted-by": "crossref", "first-page": "555", "DOI": "10.1016/S0028-3908(03)00027-3", "article-title": "Endogenous activation of group-II metabotropic glutamate receptors inhibits the hypotalamic-pituitary-adrenocortical axis", "volume": "44", "author": "Scaccianoce", "year": "2003", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB28|cit50", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1016/0028-3908(95)00061-A", "article-title": "Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate", "volume": "34", "author": "Schoepp", "year": "1995", "journal-title": "Neuropharmachology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB29|cit51", "doi-asserted-by": "crossref", "first-page": "1981", "DOI": "10.1046/j.1471-4159.1996.66051981.x", "article-title": "(1S,3R)-1- aminocyclopentane-1,3-dicarboxylic acid-induced increases in cyclic AMP formation in the neonatal rat hippocampus are mediated by a synergistic interaction between phosphoinositide- and inhibitory cyclic AMP-coupled mGluRs", "volume": "66", "author": "Schoepp", "year": "1996", "journal-title": "J. Neurochem."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB22|cit52", "doi-asserted-by": "crossref", "first-page": "1431", "DOI": "10.1016/S0028-3908(99)00092-1", "article-title": "Pharmacological agents acting at subtypes of metabotropic glutamate receptors", "volume": "38", "author": "Schoepp", "year": "1999", "journal-title": "Neuropharmacology"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB19|cit53", "doi-asserted-by": "crossref", "first-page": "857", "DOI": "10.1016/S0306-4522(02)00232-4", "article-title": "DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury", "volume": "113", "author": "Venero", "year": "2002", "journal-title": "Neuroscience"}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB30|cit54", "first-page": "37", "article-title": "Modulation of the beta-adrenergic receptor-adenylate cyclase system following acute and repeated treatment with antidepressants", "volume": "31", "author": "Weiss", "year": "1982", "journal-title": "Adv. Biochem. Psychopharmacol."}, {"key": "10.1111/j.1471-4159.2005.03141.x-BIB33|cit55", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1007/BF01256471", "article-title": "Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors", "volume": "64", "author": "Wong", "year": "1985", "journal-title": "J. Neural Transm."}], "container-title": ["Journal of Neurochemistry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1471-4159.2005.03141.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 27]], "date-time": "2019-02-27T04:49:27Z", "timestamp": 1551242967000}, "score": 34.820362, "subtitle": ["Metabotropic glutamate receptors and antidepressant treatment"], "issued": {"date-parts": [[2005, 4, 13]]}, "references-count": 54, "journal-issue": {"issue": "5"}, "URL": "http://dx.doi.org/10.1111/j.1471-4159.2005.03141.x", "relation": {"cites": []}, "ISSN": ["0022-3042", "1471-4159"], "issn-type": [{"value": "0022-3042", "type": "print"}, {"value": "1471-4159", "type": "electronic"}], "subject": ["Biochemistry", "Cellular and Molecular Neuroscience"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T05:13:53Z", "timestamp": 1574313233576}, "reference-count": 16, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 7, 26]], "date-time": "2007-07-26T00:00:00Z", "timestamp": 1185408000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol Psychiatry"], "published-print": {"date-parts": [[2007, 8]]}, "DOI": "10.1038/sj.mp.4002005", "type": "journal-article", "created": {"date-parts": [[2007, 7, 26]], "date-time": "2007-07-26T07:16:24Z", "timestamp": 1185434184000}, "page": "704-706", "source": "Crossref", "is-referenced-by-count": 29, "title": ["Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?"], "prefix": "10.1038", "volume": "12", "author": [{"given": "F", "family": "Matrisciano", "sequence": "first", "affiliation": []}, {"given": "I", "family": "Panaccione", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Zusso", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Giusti", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Tatarelli", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Iacovelli", "sequence": "additional", "affiliation": []}, {"given": "A A", "family": "Math\u00e9", "sequence": "additional", "affiliation": []}, {"given": "S H M", "family": "Gruber", "sequence": "additional", "affiliation": []}, {"given": "F", "family": "Nicoletti", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Girardi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 7, 26]]}, "reference": [{"key": "BF4002005_CR1", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.1124/jpet.106.103143", "volume": "319", "author": "X Li", "year": "2006", "unstructured": "Li X, Need AB, Baez M, Witkin JM . J Pharmacol Exp Ther 2006; 319: 254\u2013259.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF4002005_CR2", "doi-asserted-by": "publisher", "first-page": "1273", "DOI": "10.1016/j.bcp.2005.12.022", "volume": "71", "author": "A Alt", "year": "2006", "unstructured": "Alt A, Nisenbaum ES, Bleakman D, Witkin JM . Biochem Pharmacol 2006; 71: 1273\u20131288.", "journal-title": "Biochem Pharmacol"}, {"key": "BF4002005_CR3", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1358/dnp.2005.18.4.908661", "volume": "18", "author": "A Palucha", "year": "2005", "unstructured": "Palucha A, Pilc A . Drugs News Perspect 2005; 18: 262\u2013268.", "journal-title": "Drugs News Perspect"}, {"key": "BF4002005_CR4", "doi-asserted-by": "publisher", "first-page": "984", "DOI": "10.1038/sj.mp.4001551", "volume": "9", "author": "DC Javitt", "year": "2004", "unstructured": "Javitt DC . Mol Psychiatry 2004; 9: 984\u2013997,, 979.", "journal-title": "Mol Psychiatry"}, {"key": "BF4002005_CR5", "doi-asserted-by": "publisher", "first-page": "A7", "DOI": "10.1038/399a007", "volume": "399", "author": "JM Lee", "year": "1999", "unstructured": "Lee JM, Zipfel GJ, Choi DW . Nature 1999; 399: A7\u2013A14.", "journal-title": "Nature"}, {"key": "BF4002005_CR6", "doi-asserted-by": "publisher", "first-page": "40", "DOI": "10.1111/j.1471-4159.1986.tb12922.x", "volume": "46", "author": "F Nicoletti", "year": "1986", "unstructured": "Nicoletti F, Meek JL, Iadarola MJ, Chuang DM, Roth BL, Costa E . J Neurochem 1986; 46: 40\u201346.", "journal-title": "J Neurochem"}, {"key": "BF4002005_CR7", "doi-asserted-by": "publisher", "first-page": "1013", "DOI": "10.1097/00004647-200109000-00001", "volume": "2", "author": "V Bruno", "year": "2001", "unstructured": "Bruno V, Battaglia G, Copani A, D'Onofrio M, Di Iorio P, De Blasi et al. J Cereb Blood Flow Metab 2001; 2: 1013\u20131033.", "journal-title": "J Cereb Blood Flow Metab"}, {"key": "BF4002005_CR8", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0028-3908(94)00129-G", "volume": "34", "author": "JP Pin", "year": "1995", "unstructured": "Pin JP, Duvoisin R . Neuropharmacology 1995; 34: 1\u201326.", "journal-title": "Neuropharmacology"}, {"key": "BF4002005_CR9", "doi-asserted-by": "publisher", "first-page": "1431", "DOI": "10.1016/S0028-3908(99)00092-1", "volume": "38", "author": "DD Schoepp", "year": "1999", "unstructured": "Schoepp DD, Jane DE, Monn JA . Neuropharmacology 1999; 38: 1431\u20131476.", "journal-title": "Neuropharmacology"}, {"key": "BF4002005_CR10", "doi-asserted-by": "publisher", "first-page": "1545", "DOI": "10.1517/13543784.15.12.1545", "volume": "15", "author": "A Palucha", "year": "2006", "unstructured": "Palucha A . Expert Opin Investig Drugs 2006; 15: 1545\u20131553.", "journal-title": "Expert Opin Investig Drugs"}, {"key": "BF4002005_CR11", "doi-asserted-by": "publisher", "first-page": "2409", "DOI": "10.1046/j.1460-9568.2003.02667.x", "volume": "17", "author": "JF Cryan", "year": "2003", "unstructured": "Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor JP, Van Der Putten H . Eur J Neurosci 2003; 17: 2409\u20132417.", "journal-title": "Eur J Neurosci"}, {"key": "BF4002005_CR12", "doi-asserted-by": "publisher", "first-page": "1345", "DOI": "10.1111/j.1471-4159.2005.03141.x", "volume": "93", "author": "F Matrisciano", "year": "2005", "unstructured": "Matrisciano F, Scaccianoce S, Del Bianco P, Panaccione I, Canudas AM, Battaglia G et al. J Neurochem 2005; 93: 1345\u20131352.", "journal-title": "J Neurochem"}, {"key": "BF4002005_CR13", "doi-asserted-by": "publisher", "first-page": "1008", "DOI": "10.1016/S0028-3908(02)00057-6", "volume": "42", "author": "F Matrisciano", "year": "2002", "unstructured": "Matrisciano F, Storto M, Ngomba RT, Cappuccio I, Caricatole A, Scaccianoce S et al. Neuropharmacology 2002; 42: 1008\u20131015.", "journal-title": "Neuropharmacology"}, {"key": "BF4002005_CR14", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1615/CritRevNeurobiol.v16.i12.60", "volume": "16", "author": "M Zusso", "year": "2004", "unstructured": "Zusso M, Debetto P, Guidolin D, Giusti P . Crit Rev Neurobiol 2004; 16: 59\u201365.", "journal-title": "Crit Rev Neurobiol"}, {"key": "BF4002005_CR15", "doi-asserted-by": "publisher", "first-page": "739", "DOI": "10.1016/j.neubiorev.2005.03.015", "volume": "29", "author": "DH Overstreet", "year": "2005", "unstructured": "Overstreet DH, Friedman E, Math\u00e9 AA, Yadid G . Neurosci Biobehav Rev 2005; 29: 739\u2013759.", "journal-title": "Neurosci Biobehav Rev"}, {"key": "BF4002005_CR16", "doi-asserted-by": "publisher", "first-page": "821", "DOI": "10.1016/0361-9230(92)90267-2", "volume": "28", "author": "GD Schiller", "year": "1992", "unstructured": "Schiller GD, Pucilowski O, Wienicke C, Overstreet DH . Brain Res Bull 1992; 28: 821\u2013823.", "journal-title": "Brain Res Bull"}], "container-title": ["Molecular Psychiatry"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/4002005.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4002005", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4002005.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T09:43:23Z", "timestamp": 1556099003000}, "score": 33.931976, "issued": {"date-parts": [[2007, 7, 26]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2007, 8]]}, "issue": "8"}, "alternative-id": ["BF4002005"], "URL": "http://dx.doi.org/10.1038/sj.mp.4002005", "relation": {"cites": []}, "ISSN": ["1359-4184", "1476-5578"], "issn-type": [{"value": "1359-4184", "type": "print"}, {"value": "1476-5578", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T03:42:54Z", "timestamp": 1574307774071}, "reference-count": 63, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 9, 1]], "date-time": "2009-09-01T00:00:00Z", "timestamp": 1251763200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[2009, 9]]}, "DOI": "10.1016/j.neuropharm.2009.06.005", "type": "journal-article", "created": {"date-parts": [[2009, 6, 19]], "date-time": "2009-06-19T08:25:03Z", "timestamp": 1245399903000}, "page": "227-234", "source": "Crossref", "is-referenced-by-count": 24, "title": ["The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems"], "prefix": "10.1016", "volume": "57", "author": [{"given": "K.", "family": "Stachowicz", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "K\u0142odzi\u0144ska", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Palucha-Poniewiera", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Schann", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Neuville", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Pilc", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0028390809001609?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0028390809001609?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 21]], "date-time": "2019-05-21T00:13:26Z", "timestamp": 1558397606000}, "score": 30.577286, "issued": {"date-parts": [[2009, 9]]}, "references-count": 63, "journal-issue": {"published-print": {"date-parts": [[2009, 9]]}, "issue": "3"}, "alternative-id": ["S0028390809001609"], "URL": "http://dx.doi.org/10.1016/j.neuropharm.2009.06.005", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T01:21:54Z", "timestamp": 1575163314414}, "reference-count": 0, "publisher": "Clarivate Analytics (US)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug News Perspect"], "published-print": {"date-parts": [[2005]]}, "DOI": "10.1358/dnp.2005.18.4.908661", "type": "journal-article", "created": {"date-parts": [[2005, 7, 26]], "date-time": "2005-07-26T17:24:23Z", "timestamp": 1122398663000}, "page": "262", "source": "Crossref", "is-referenced-by-count": 52, "title": ["The involvement of glutamate in the pathophysiology of depression"], "prefix": "10.1358", "volume": "18", "author": [{"given": "A.", "family": "Palucha", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Pilc", "sequence": "additional", "affiliation": []}], "member": "71", "container-title": ["Drug News & Perspectives"], "language": "en", "deposited": {"date-parts": [[2011, 8, 12]], "date-time": "2011-08-12T16:48:05Z", "timestamp": 1313167685000}, "score": 30.245682, "issued": {"date-parts": [[2005]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1358/dnp.2005.18.4.908661", "ISSN": ["0214-0934"], "issn-type": [{"value": "0214-0934", "type": "print"}], "subject": ["Pharmacology", "Drug Discovery", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T13:47:06Z", "timestamp": 1574344026472}, "reference-count": 16, "publisher": "Elsevier", "isbn-type": [{"value": "9780080552323", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 1, 1]], "date-time": "2007-01-01T00:00:00Z", "timestamp": 1167609600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2007]]}, "DOI": "10.1016/b978-008055232-3.60987-0", "type": "book-chapter", "created": {"date-parts": [[2008, 1, 10]], "date-time": "2008-01-10T20:30:57Z", "timestamp": 1199997057000}, "page": "1-2", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Metabotropic Glutamate Receptor Agents"], "prefix": "10.1016", "author": [{"given": "John A.", "family": "Davies", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["xPharm: The Comprehensive Pharmacology Reference"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780080552323609870?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780080552323609870?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 1]], "date-time": "2019-01-01T16:53:10Z", "timestamp": 1546361590000}, "score": 29.912527, "issued": {"date-parts": [[2007]]}, "ISBN": ["9780080552323"], "references-count": 16, "URL": "http://dx.doi.org/10.1016/b978-008055232-3.60987-0"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T23:16:47Z", "timestamp": 1575155807353}, "reference-count": 0, "publisher": "Clarivate Analytics (US)", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs Fut"], "published-print": {"date-parts": [[2002]]}, "DOI": "10.1358/dof.2002.027.08.687386", "type": "journal-article", "created": {"date-parts": [[2005, 6, 17]], "date-time": "2005-06-17T13:04:16Z", "timestamp": 1119013456000}, "page": "753", "source": "Crossref", "is-referenced-by-count": 14, "title": ["A role for glutamate in the treatment of anxiety and depression: Focus on group I metabotropic glutamate (mGlu) receptors"], "prefix": "10.1358", "volume": "27", "author": [{"given": "A.", "family": "Pilc", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Klodzinska", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Nowak", "sequence": "additional", "affiliation": []}], "member": "71", "container-title": ["Drugs of the Future"], "language": "en", "deposited": {"date-parts": [[2011, 8, 8]], "date-time": "2011-08-08T17:06:09Z", "timestamp": 1312823169000}, "score": 29.861927, "issued": {"date-parts": [[2002]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2002]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1358/dof.2002.027.08.687386", "ISSN": ["0377-8282"], "issn-type": [{"value": "0377-8282", "type": "print"}], "subject": ["Pharmacology (medical)", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T18:56:07Z", "timestamp": 1574103367761}, "reference-count": 25, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 1, 1]], "date-time": "2001-01-01T00:00:00Z", "timestamp": 978307200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropharmacology"], "published-print": {"date-parts": [[2001, 1]]}, "DOI": "10.1016/s0028-3908(00)00128-3", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T21:05:54Z", "timestamp": 1027631154000}, "page": "170-177", "source": "Crossref", "is-referenced-by-count": 32, "title": ["Pharmacological profiles of the metabotropic glutamate receptor ligands [3H]L-AP4 and [3H]CPPG"], "prefix": "10.1016", "volume": "40", "author": [{"given": "Mark A", "family": "Naples", "sequence": "first", "affiliation": []}, {"given": "David R", "family": "Hampson", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuropharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0028390800001283?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0028390800001283?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 20]], "date-time": "2019-04-20T18:30:01Z", "timestamp": 1555785001000}, "score": 29.643116, "issued": {"date-parts": [[2001, 1]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2001, 1]]}, "issue": "2"}, "alternative-id": ["S0028390800001283"], "URL": "http://dx.doi.org/10.1016/s0028-3908(00)00128-3", "ISSN": ["0028-3908"], "issn-type": [{"value": "0028-3908", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T01:43:50Z", "timestamp": 1574127830695}, "reference-count": 46, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 6, 1]], "date-time": "2000-06-01T00:00:00Z", "timestamp": 959817600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today"], "published-print": {"date-parts": [[2000, 6]]}, "DOI": "10.1016/s1359-6446(00)01499-9", "type": "journal-article", "created": {"date-parts": [[2004, 5, 26]], "date-time": "2004-05-26T17:40:37Z", "timestamp": 1085593237000}, "page": "20-26", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Discovery of subtype-selective metabotropic glutamate receptor ligands using functional HTS assays"], "prefix": "10.1016", "volume": "5", "author": [{"given": "Mark A", "family": "Varney", "sequence": "first", "affiliation": []}, {"given": "Carla M", "family": "Suto", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359644600014999?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359644600014999?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 8]], "date-time": "2019-02-08T01:29:29Z", "timestamp": 1549589369000}, "score": 29.643116, "issued": {"date-parts": [[2000, 6]]}, "references-count": 46, "alternative-id": ["S1359644600014999"], "URL": "http://dx.doi.org/10.1016/s1359-6446(00)01499-9", "ISSN": ["1359-6446"], "issn-type": [{"value": "1359-6446", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T09:42:11Z", "timestamp": 1575366131209}, "reference-count": 41, "publisher": "Royal Society of Chemistry (RSC)", "issue": "2", "license": [{"URL": "http://rsc.li/journals-terms-of-use", "start": {"date-parts": [[2019, 12, 12]], "date-time": "2019-12-12T00:00:00Z", "timestamp": 1576108800000}, "delay-in-days": 345, "content-version": "am"}], "content-domain": {"domain": ["rsc.org"], "crossmark-restriction": true}, "short-container-title": ["Med. Chem. Commun."], "abstract": "<p>Metabotropic glutamate type 7 (mGlu<sub>7</sub>) receptor is a member of the group III family of mGlu receptors.</p>", "DOI": "10.1039/c8md00524a", "type": "journal-article", "created": {"date-parts": [[2018, 12, 12]], "date-time": "2018-12-12T07:34:13Z", "timestamp": 1544600053000}, "page": "193-199", "update-policy": "http://dx.doi.org/10.1039/rsc_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Progress toward allosteric ligands of metabotropic glutamate 7 (mGlu7) receptor: 2008\u2013present"], "prefix": "10.1039", "volume": "10", "author": [{"ORCID": "http://orcid.org/0000-0001-7911-3160", "authenticated-orcid": false, "given": "Henar", "family": "V\u00e1zquez-Villa", "sequence": "first", "affiliation": [{"name": "Departamento de Qu\u00edmica Org\u00e1nica"}, {"name": "Facultad de Ciencias Qu\u00edmicas"}, {"name": "Universidad Complutense de Madrid"}, {"name": "E-28040 Madrid"}, {"name": "Spain"}]}, {"ORCID": "http://orcid.org/0000-0002-4225-758X", "authenticated-orcid": false, "given": "Andr\u00e9s A.", "family": "Trabanco", "sequence": "additional", "affiliation": [{"name": "Discovery Sciences"}, {"name": "Medicinal Chemistry Department"}, {"name": "Janssen Research & Development"}, {"name": "45007 Toledo"}, {"name": "Spain"}]}], "member": "292", "published-online": {"date-parts": [[2019]]}, "reference": [{"key": "C8MD00524A-(cit1)/*[position()=1]", "author": "Conn", "volume": "37", "first-page": "205", "year": "1997", "journal-title": "Annu. Rev. Pharmacol. Toxicol.", "DOI": "10.1146/annurev.pharmtox.37.1.205", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit2)/*[position()=1]", "author": "Niswender", "volume": "50", "first-page": "295", "year": "2010", "journal-title": "Annu. Rev. Pharmacol. Toxicol.", "DOI": "10.1146/annurev.pharmtox.011008.145533", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit3)/*[position()=1]", "author": "Kew", "volume": "179", "first-page": "4", "year": "2005", "journal-title": "Psychopharmacology", "DOI": "10.1007/s00213-005-2200-z", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit4)/*[position()=1]", "author": "Owen", "volume": "2", "first-page": "394", "year": "2011", "journal-title": "ACS Chem. Neurosci.", "DOI": "10.1021/cn2000124", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit5)/*[position()=1]", "author": "Jin", "volume": "8", "first-page": "501", "year": "2017", "journal-title": "Med. Chem. Commun.", "DOI": "10.1039/C6MD00612D", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit6)/*[position()=1]", "author": "Lavreysen", "volume": "15", "first-page": "671", "year": "2008", "journal-title": "Curr. Med. Chem.", "DOI": "10.2174/092986708783885246", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit7)/*[position()=1]", "author": "Kinzie", "volume": "69", "first-page": "167", "year": "1995", "journal-title": "Neuroscience", "DOI": "10.1016/0306-4522(95)00244-D", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit8)/*[position()=1]", "author": "Makoff", "volume": "40", "first-page": "165", "year": "1996", "journal-title": "Brain Res. Mol. Brain Res.", "DOI": "10.1016/0169-328X(96)00110-6", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit9)/*[position()=1]", "author": "Wright", "volume": "362", "first-page": "546", "year": "2000", "journal-title": "Naunyn-Schmiedeberg's Arch. Pharmacol.", "DOI": "10.1007/s002100000305", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit10)/*[position()=1]", "author": "Kammermeier", "volume": "16", "first-page": "17", "year": "2015", "journal-title": "BMC Neurosci.", "DOI": "10.1186/s12868-015-0154-6", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit11)/*[position()=1]", "author": "Dalezios", "volume": "12", "first-page": "961", "year": "2002", "journal-title": "Cereb. Cortex", "DOI": "10.1093/cercor/12.9.961", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit12)/*[position()=1]", "author": "Callaerts-Vegh", "volume": "26", "first-page": "6573", "year": "2006", "journal-title": "J. Neurosci.", "DOI": "10.1523/JNEUROSCI.1497-06.2006", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit13)/*[position()=1]", "author": "Cryan", "volume": "17", "first-page": "2409", "year": "2003", "journal-title": "Eur. J. Neurosci.", "DOI": "10.1046/j.1460-9568.2003.02667.x", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit14)/*[position()=1]", "author": "Hovels\u00f8", "volume": "10", "first-page": "12", "year": "2012", "journal-title": "Curr. Neuropharmacol.", "DOI": "10.2174/157015912799362805", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit15)/*[position()=1]", "author": "Sansig", "volume": "21", "first-page": "8734", "year": "2001", "journal-title": "J. Neurosci.", "DOI": "10.1523/JNEUROSCI.21-22-08734.2001", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit16)/*[position()=1]", "author": "Liu", "volume": "168", "first-page": "258", "year": "2015", "journal-title": "Am. J. Med. Genet., Part B", "DOI": "10.1002/ajmg.b.32306", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit17)/*[position()=1]", "author": "Breen", "volume": "168", "first-page": "840", "year": "2011", "journal-title": "Am. J. Psychiatry", "DOI": "10.1176/appi.ajp.2011.10091342", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit18)/*[position()=1]", "author": "Mick", "volume": "147", "first-page": "1412", "year": "2008", "journal-title": "Am. J. Med. Genet., Part B", "DOI": "10.1002/ajmg.b.30865", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit19)/*[position()=1]", "author": "Alliey-Rodriguez", "volume": "21", "first-page": "190", "year": "2011", "journal-title": "Psychiatr. Genet.", "DOI": "10.1097/YPG.0b013e3283457a31", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit20)/*[position()=1]", "author": "Ohtsuki", "volume": "101", "first-page": "9", "year": "2008", "journal-title": "Schizophr. Res.", "DOI": "10.1016/j.schres.2008.01.027", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit21)/*[position()=1]", "author": "Mitsukawa", "volume": "102", "first-page": "18712", "year": "2005", "journal-title": "Proc. Natl. Acad. Sci. U. S. A.", "DOI": "10.1073/pnas.0508063102", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit22)/*[position()=1]", "author": "Conn", "volume": "103", "first-page": "251", "year": "2006", "journal-title": "Proc. Natl. Acad. Sci. U. S. A.", "DOI": "10.1073/pnas.0510051103", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit23)/*[position()=1]", "author": "Rizzo", "volume": "338", "first-page": "345", "year": "2011", "journal-title": "J. Pharmacol. Exp. Ther.", "DOI": "10.1124/jpet.110.177378", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit24)/*[position()=1]", "author": "Ahnaou", "volume": "311", "first-page": "287", "year": "2016", "journal-title": "Behav. Brain Res.", "DOI": "10.1016/j.bbr.2016.05.035", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit25)/*[position()=1]", "author": "Suzuki", "volume": "323", "first-page": "147", "year": "2007", "journal-title": "J. Pharmacol. Exp. Ther.", "DOI": "10.1124/jpet.107.124701", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit26)/*[position()=1]", "author": "Nakamura", "volume": "20", "first-page": "726", "year": "2010", "journal-title": "Bioorg. Med. Chem. Lett.", "DOI": "10.1016/j.bmcl.2009.11.070", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit27)/*[position()=1]", "author": "Hikichi", "volume": "639", "first-page": "106", "year": "2010", "journal-title": "Eur. J. Pharmacol.", "DOI": "10.1016/j.ejphar.2009.08.047", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit28)/*[position()=1]", "author": "Bahi", "volume": "101", "first-page": "193", "year": "2012", "journal-title": "Addict. Biol."}, {"issue": "44", "key": "C8MD00524A-(cit29)/*[position()=1]", "first-page": "1", "volume": "9", "author": "Palazzo", "year": "2013", "journal-title": "Mol. Pain"}, {"key": "C8MD00524A-(cit30)/*[position()=1]", "author": "Palazzo", "volume": "156", "first-page": "1060", "year": "2015", "journal-title": "Pain"}, {"issue": "54", "key": "C8MD00524A-(cit31)/*[position()=1]", "first-page": "1", "volume": "3", "author": "Yamasaki", "year": "2013", "journal-title": "EJNMMI Res."}, {"key": "C8MD00524A-(cit32)/*[position()=1]", "author": "Tresadern", "volume": "57", "first-page": "2976", "year": "2017", "journal-title": "J. Chem. Inf. Model.", "DOI": "10.1021/acs.jcim.7b00338", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit33)/*[position()=1]", "author": "Cid", "journal-title": "ACS Chem. Neurosci.", "DOI": "10.1021/acschemneuro.8b00331", "doi-asserted-by": "publisher"}, {"key": "C8MD00524A-(cit37)/*[position()=1]", "author": "Mart\u00edn", "volume": "596", "first-page": "921", "year": "2018", "journal-title": "J. Physiol.", "DOI": "10.1113/JP275371", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit38)/*[position()=1]", "author": "Jalan-Sakrikar", "volume": "5", "first-page": "1221", "year": "2014", "journal-title": "ACS Chem. Neurosci.", "DOI": "10.1021/cn500153z", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit39)/*[position()=1]", "author": "Engers", "volume": "52", "first-page": "4115", "year": "2009", "journal-title": "J. Med. Chem.", "DOI": "10.1021/jm9005065", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit40)/*[position()=1]", "author": "Abe", "volume": "8", "first-page": "1110", "year": "2017", "journal-title": "ACS Med. Chem. Lett.", "DOI": "10.1021/acsmedchemlett.7b00317", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit41)/*[position()=1]", "author": "Conn", "volume": "13", "first-page": "692", "year": "2014", "journal-title": "Nat. Rev. Drug Discovery", "DOI": "10.1038/nrd4308", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit42)/*[position()=1]", "author": "Kalinichev", "volume": "334", "first-page": "624", "year": "2013", "journal-title": "J. Pharmacol. Exp. Ther.", "DOI": "10.1124/jpet.112.200915", "doi-asserted-by": "crossref"}, {"key": "C8MD00524A-(cit43)/*[position()=1]", "author": "Cieslik", "journal-title": "Front. Mol. Neurosci.", "DOI": "10.3389/fnmol.2018.00316", "doi-asserted-by": "publisher"}, {"key": "C8MD00524A-(cit44)/*[position()=1]", "author": "Reed", "volume": "8", "first-page": "1326", "year": "2017", "journal-title": "ACS Med. Chem. Lett.", "DOI": "10.1021/acsmedchemlett.7b00429", "doi-asserted-by": "crossref"}], "container-title": ["MedChemComm"], "language": "en", "link": [{"URL": "http://pubs.rsc.org/en/content/articlepdf/2019/MD/C8MD00524A", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 20]], "date-time": "2019-02-20T22:12:25Z", "timestamp": 1550700745000}, "score": 29.643116, "issued": {"date-parts": [[2019]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2019, 2, 20]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1039/c8md00524a", "relation": {"cites": []}, "ISSN": ["2040-2503", "2040-2511"], "issn-type": [{"value": "2040-2503", "type": "print"}, {"value": "2040-2511", "type": "electronic"}], "subject": ["Biochemistry", "Pharmaceutical Science"], "assertion": [{"value": "This document is Similarity Check deposited", "name": "similarity_check", "explanation": {"URL": "https://www.crossref.org/services/similarity-check/"}, "group": {"name": "similarity_check", "label": "SIMILARITY CHECK"}}, {"value": "Henar V\u00e1zquez-Villa (ORCID)", "URL": "http://orcid.org/0000-0001-7911-3160", "name": "identifier", "group": {"name": "author_identifiers", "label": "IDENTIFIERS"}}, {"value": "Andr\u00e9s A. Trabanco (ORCID)", "URL": "http://orcid.org/0000-0002-4225-758X", "name": "identifier", "group": {"name": "author_identifiers", "label": "IDENTIFIERS"}}, {"value": "Single-blind", "order": 2, "name": "peer_review_method", "group": {"name": "peer_review_method", "label": "PEER REVIEW METHOD"}}, {"value": "Received 17 October 2018; Accepted 11 December 2018;  Accepted Manuscript published 12 December 2018;  Advance Article published 9 January 2019;  Version of Record published 20 February 2019", "order": 1, "name": "history", "group": {"name": "publication_history", "label": "PUBLICATION HISTORY"}}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T08:22:31Z", "timestamp": 1575274951172}, "reference-count": 21, "publisher": "Future Science Ltd", "issue": "13", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Future Medicinal Chemistry"], "published-print": {"date-parts": [[2013, 9]]}, "DOI": "10.4155/fmc.13.137", "type": "journal-article", "created": {"date-parts": [[2013, 9, 11]], "date-time": "2013-09-11T16:05:28Z", "timestamp": 1378915528000}, "page": "1471-1474", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Metabotropic glutamate receptor 5 in schizophrenia: emerging evidence for the development of antipsychotic drugs"], "prefix": "10.4155", "volume": "5", "author": [{"given": "Kelly A", "family": "Newell", "sequence": "first", "affiliation": []}], "member": "2641", "reference": [{"key": "ref-1", "DOI": "10.1093/schbul/sbs076", "doi-asserted-by": "publisher"}, {"key": "ref-2", "author": "Weickert", "year": "2012", "journal-title": "Mol. Psychiatry"}, {"key": "ref-3", "DOI": "10.1016/j.schres.2013.01.018", "doi-asserted-by": "publisher"}, {"key": "ref-4", "DOI": "10.1016/j.neubiorev.2012.12.005", "doi-asserted-by": "publisher"}, {"key": "ref-5", "DOI": "10.1093/brain/awr155", "doi-asserted-by": "publisher"}, {"key": "ref-6", "DOI": "10.1038/npp.2009.30", "doi-asserted-by": "publisher"}, {"key": "ref-7", "DOI": "10.1074/jbc.M806139200", "doi-asserted-by": "publisher"}, {"key": "ref-8", "DOI": "10.1016/j.devbrainres.2004.02.003", "doi-asserted-by": "publisher"}, {"key": "ref-9", "DOI": "10.1016/j.neuron.2011.02.045", "doi-asserted-by": "publisher"}, {"key": "ref-10", "DOI": "10.1038/nrn3504", "doi-asserted-by": "publisher"}, {"key": "ref-11", "DOI": "10.1523/JNEUROSCI.4722-05.2006", "doi-asserted-by": "publisher"}, {"key": "ref-12", "DOI": "10.1001/jamapsychiatry.2013.1195", "doi-asserted-by": "publisher"}, {"key": "ref-13", "DOI": "10.1017/S1461145708009085", "doi-asserted-by": "publisher"}, {"key": "ref-14", "DOI": "10.1016/j.neuropharm.2010.11.013", "doi-asserted-by": "publisher"}, {"key": "ref-15", "DOI": "10.1016/j.neuropharm.2012.07.030", "doi-asserted-by": "publisher"}, {"key": "ref-16", "DOI": "10.1124/mol.110.067207", "doi-asserted-by": "publisher"}, {"key": "ref-17", "DOI": "10.1016/j.neuropharm.2012.07.039", "doi-asserted-by": "publisher"}, {"key": "ref-18", "DOI": "10.1124/jpet.104.079244", "doi-asserted-by": "publisher"}, {"key": "ref-19", "DOI": "10.3109/10799893.2010.487492", "doi-asserted-by": "publisher"}, {"key": "ref-20", "DOI": "10.1124/mol.112.082891", "doi-asserted-by": "publisher"}, {"key": "ref-21", "DOI": "10.1038/tpj.2010.90", "doi-asserted-by": "publisher"}], "container-title": ["Future Medicinal Chemistry"], "language": "en", "link": [{"URL": "http://www.future-science.com/doi/pdf/10.4155/fmc.13.137", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:14:45Z", "timestamp": 1574244885000}, "score": 29.145748, "issued": {"date-parts": [[2013, 9]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[2013, 9]]}, "issue": "13"}, "alternative-id": ["10.4155/fmc.13.137"], "URL": "http://dx.doi.org/10.4155/fmc.13.137", "relation": {"cites": []}, "ISSN": ["1756-8919", "1756-8927"], "issn-type": [{"value": "1756-8919", "type": "print"}, {"value": "1756-8927", "type": "electronic"}], "subject": ["Molecular Medicine", "Pharmacology", "Drug Discovery"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:15:19Z", "timestamp": 1574115319662}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 4, 1]], "date-time": "2003-04-01T00:00:00Z", "timestamp": 1049155200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Amino Acids"], "published-print": {"date-parts": [[2003, 4, 1]]}, "DOI": "10.1007/s00726-002-0405-6", "type": "journal-article", "created": {"date-parts": [[2004, 3, 20]], "date-time": "2004-03-20T14:12:16Z", "timestamp": 1079791936000}, "page": "303-310", "source": "Crossref", "is-referenced-by-count": 5, "title": ["3-Carboxy-4-phosphonocyclopentane amino acids: New metabotropic glutamate receptor ligands"], "prefix": "10.1007", "volume": "24", "author": [{"given": "E.", "family": "Bourrat", "sequence": "first", "affiliation": []}, {"given": "G.", "family": "Bertho", "sequence": "additional", "affiliation": []}, {"given": "J.-P.", "family": "Pin", "sequence": "additional", "affiliation": []}, {"given": "F. C.", "family": "Acher", "sequence": "additional", "affiliation": []}, {"given": "A.-S.", "family": "Bessis", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Vadesne", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Amino Acids"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00726-002-0405-6.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00726-002-0405-6/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00726-002-0405-6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 29]], "date-time": "2019-05-29T05:36:09Z", "timestamp": 1559108169000}, "score": 28.92513, "issued": {"date-parts": [[2003, 4, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 4, 1]]}, "issue": "3"}, "alternative-id": ["JAXDM9XUA7HRL7UC"], "URL": "http://dx.doi.org/10.1007/s00726-002-0405-6", "ISSN": ["0939-4451", "1438-2199"], "issn-type": [{"value": "0939-4451", "type": "print"}, {"value": "1438-2199", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:11:11Z", "timestamp": 1574136671837}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2000, 8, 31]], "date-time": "2000-08-31T00:00:00Z", "timestamp": 967680000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Amino Acids"], "published-print": {"date-parts": [[2000, 8, 31]]}, "DOI": "10.1007/s007260070038", "type": "journal-article", "created": {"date-parts": [[2003, 2, 12]], "date-time": "2003-02-12T18:05:56Z", "timestamp": 1045073156000}, "page": "95-101", "source": "Crossref", "is-referenced-by-count": 14, "title": ["The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity"], "prefix": "10.1007", "volume": "19", "author": [{"given": "S.", "family": "Wolfarth", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Konieczny", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Lorenc-Koci", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Ossowska", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Pilc", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Amino Acids"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s007260070038.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s007260070038/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s007260070038", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 29]], "date-time": "2019-05-29T05:42:17Z", "timestamp": 1559108537000}, "score": 28.92513, "issued": {"date-parts": [[2000, 8, 31]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 8, 31]]}, "issue": "1"}, "alternative-id": ["CLAPBFTYG0RV6TJY"], "URL": "http://dx.doi.org/10.1007/s007260070038", "ISSN": ["0939-4451", "1438-2199"], "issn-type": [{"value": "0939-4451", "type": "print"}, {"value": "1438-2199", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T00:03:32Z", "timestamp": 1575245012866}, "reference-count": 80, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 9, 1]], "date-time": "2013-09-01T00:00:00Z", "timestamp": 1377993600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Behavioural Brain Research"], "published-print": {"date-parts": [[2013, 9]]}, "DOI": "10.1016/j.bbr.2013.06.032", "type": "journal-article", "created": {"date-parts": [[2013, 7, 1]], "date-time": "2013-07-01T22:33:04Z", "timestamp": 1372717984000}, "page": "9-16", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Effects of group II and III metabotropic glutamate receptor ligands on conditioned taste aversion learning"], "prefix": "10.1016", "volume": "253", "author": [{"given": "D.", "family": "Klakotskaia", "sequence": "first", "affiliation": []}, {"given": "A.K.", "family": "Ramsey", "sequence": "additional", "affiliation": []}, {"given": "S.W.", "family": "Fowler", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Serfozo", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Simonyi", "sequence": "additional", "affiliation": []}, {"given": "T.R.", "family": "Schachtman", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Behavioural Brain Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0166432813003951?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0166432813003951?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 16]], "date-time": "2019-07-16T22:23:22Z", "timestamp": 1563315802000}, "score": 28.92513, "issued": {"date-parts": [[2013, 9]]}, "references-count": 80, "alternative-id": ["S0166432813003951"], "URL": "http://dx.doi.org/10.1016/j.bbr.2013.06.032", "ISSN": ["0166-4328"], "issn-type": [{"value": "0166-4328", "type": "print"}], "subject": ["Behavioral Neuroscience"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Effects of group II and III metabotropic glutamate receptor ligands on conditioned taste aversion learning", "name": "articletitle", "label": "Article Title"}, {"value": "Behavioural Brain Research", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.bbr.2013.06.032", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2013 Published by Elsevier B.V.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T22:21:05Z", "timestamp": 1574461265363}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 3, 1]], "date-time": "2012-03-01T00:00:00Z", "timestamp": 1330560000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2012, 3]]}, "DOI": "10.1016/s0924-977x(12)70047-0", "type": "journal-article", "created": {"date-parts": [[2012, 3, 20]], "date-time": "2012-03-20T10:39:30Z", "timestamp": 1332239970000}, "page": "S44-S45", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P.2.015 An anxiolytic but not antidepressant-like activity of a novel positive modulator of mGlu4 receptor Lu AF21394"], "prefix": "10.1016", "volume": "22", "author": [{"given": "A.", "family": "Slawinska", "sequence": "first", "affiliation": []}, {"given": "J.M.", "family": "Wieronska", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Stachowicz", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Palucha-Poniewiera", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Pilc", "sequence": "additional", "affiliation": []}, {"given": "M.A.", "family": "Uberti", "sequence": "additional", "affiliation": []}, {"given": "M.D.", "family": "Bacolod", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Doller", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X12700470?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X12700470?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 25]], "date-time": "2018-11-25T03:25:54Z", "timestamp": 1543116354000}, "score": 28.728836, "issued": {"date-parts": [[2012, 3]]}, "references-count": 0, "alternative-id": ["S0924977X12700470"], "URL": "http://dx.doi.org/10.1016/s0924-977x(12)70047-0", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:54:52Z", "timestamp": 1574132092101}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 1, 1]], "date-time": "2001-01-01T00:00:00Z", "timestamp": 978307200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2001, 1]]}, "DOI": "10.1016/s0924-977x(01)80233-9", "type": "journal-article", "created": {"date-parts": [[2002, 10, 11]], "date-time": "2002-10-11T17:02:04Z", "timestamp": 1034355724000}, "page": "S228-S229", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Potential antidepressant-like effects of MPEP, a potent, selective and systemically active mGluR5 receptor antagonist"], "prefix": "10.1016", "volume": "11", "author": [{"given": "A.", "family": "Palucha", "sequence": "first", "affiliation": []}, {"given": "P.", "family": "Branski", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Kroczka", "sequence": "additional", "affiliation": []}, {"given": "J.M.", "family": "Wieronska", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Pilc", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X01802339?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X01802339?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 11]], "date-time": "2019-04-11T10:51:47Z", "timestamp": 1554979907000}, "score": 28.655186, "issued": {"date-parts": [[2001, 1]]}, "references-count": 0, "alternative-id": ["S0924977X01802339"], "URL": "http://dx.doi.org/10.1016/s0924-977x(01)80233-9", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:39:46Z", "timestamp": 1574732386278}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2015, 9]]}, "DOI": "10.1016/s0924-977x(15)30491-0", "type": "journal-article", "created": {"date-parts": [[2015, 10, 1]], "date-time": "2015-10-01T21:06:33Z", "timestamp": 1443733593000}, "page": "S378-S379", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P.2.a.007 The potential antidepressant effect of the joint administration of ketamine and mGLU2/3 receptor antagonist, LY341495 in the forced swim test in rats"], "prefix": "10.1016", "volume": "25", "author": [{"given": "K.", "family": "Podkowa", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Pile", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Palucha-Poniewiera", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X15304910?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X15304910?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 19]], "date-time": "2018-09-19T01:23:18Z", "timestamp": 1537320198000}, "score": 28.524208, "issued": {"date-parts": [[2015, 9]]}, "references-count": 0, "alternative-id": ["S0924977X15304910"], "URL": "http://dx.doi.org/10.1016/s0924-977x(15)30491-0", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:18:34Z", "timestamp": 1574158714933}, "reference-count": 33, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 12, 24]], "date-time": "2004-12-24T00:00:00Z", "timestamp": 1103846400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2005, 4]]}, "DOI": "10.1007/s00213-004-2098-x", "type": "journal-article", "created": {"date-parts": [[2004, 12, 23]], "date-time": "2004-12-23T14:35:33Z", "timestamp": 1103812533000}, "page": "284-291", "source": "Crossref", "is-referenced-by-count": 83, "title": ["Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice"], "prefix": "10.1007", "volume": "179", "author": [{"given": "A.-M.", "family": "Linden", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Shannon", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Baez", "sequence": "additional", "affiliation": []}, {"given": "J. L.", "family": "Yu", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Koester", "sequence": "additional", "affiliation": []}, {"given": "D. D.", "family": "Schoepp", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2004, 12, 24]]}, "reference": [{"key": "CR1", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/S0165-0173(98)00050-2", "volume": "29", "author": "R Anwyl", "year": "1999", "unstructured": "Anwyl R (1999) Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Rev 29:83?120", "journal-title": "Brain Res Rev"}, {"key": "CR2", "doi-asserted-by": "crossref", "first-page": "889", "DOI": "10.1046/j.1471-4159.2000.0750889.x", "volume": "75", "author": "J Cartmell", "year": "2000", "unstructured": "Cartmell J, Schoepp DD (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75:889?907", "journal-title": "J Neurochem"}, {"key": "CR3", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1146/annurev.pharmtox.37.1.205", "volume": "37", "author": "PJ Conn", "year": "1997", "unstructured": "Conn PJ, Pin J-P (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205?237", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "CR4", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1177/026988110101500203", "volume": "15", "author": "P Ferris", "year": "2001", "unstructured": "Ferris P, Seward E, Dawson GR (2001) Interactions between LY354740, a group II metabotropic agonist and the GABAA-benzodiazepine receptor complex in the rat elevated plus maze. J Psychopharmacol 15:76?82", "journal-title": "J Psychopharmacol"}, {"key": "CR5", "unstructured": "Grillon C, Cordova J, Levine L, Morgan C III (2003) Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans. Psychopharmacology (Berl)"}, {"key": "CR6", "first-page": "651", "volume": "284", "author": "DR Helton", "year": "1998", "unstructured": "Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ (1998) Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group III metabotropic glutamate receptors. J Pharmacol Exp Ther 284:651?660", "journal-title": "J Pharmacol Exp Ther"}, {"key": "CR7", "doi-asserted-by": "crossref", "first-page": "907", "DOI": "10.1016/j.neuropharm.2004.01.018", "volume": "46", "author": "GA Higgins", "year": "2004", "unstructured": "Higgins GA, Ballard TM, Kew JNC, Richards JG, Kemp JA, Adam G, Woltering T, Nakanishi S, Mutel V (2004) Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology 46:907?917", "journal-title": "Neuropharmacology"}, {"key": "CR8", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1007/BF00401402", "volume": "13", "author": "S Irwin", "year": "1968", "unstructured": "Irwin S (1968) Comprehensive observational assessment: IA. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13:222?257", "journal-title": "Psychopharmacologia"}, {"key": "CR9", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1016/S0028-3908(02)00084-9", "volume": "43", "author": "JNC Kew", "year": "2002", "unstructured": "Kew JNC, Pflimlin M-C, Kemp JA, Mutel V (2002) Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 ?/? mice. Neuropharmacology 43:215?221", "journal-title": "Neuropharmacology"}, {"key": "CR10", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0028-3908(97)00191-3", "volume": "37", "author": "A Kingston", "year": "1998", "unstructured": "Kingston A, Ornstein P, Wright R, Johnson B, Mayne N, Burnett J, Belagaje R, Wu S, Schoepp D (1998) LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37:1?12", "journal-title": "Neuropharmacology"}, {"key": "CR11", "doi-asserted-by": "crossref", "first-page": "1831", "DOI": "10.1016/S0028-3908(99)00066-0", "volume": "38", "author": "A Klodzinska", "year": "1999", "unstructured": "Klodzinska A, Chojnacka-Wojcik E, Palucha A, Branski P, Popik P, Pilc A (1999) Potential anti-anxiety, anti-addictive effects of LY354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology 38:1831?1839", "journal-title": "Neuropharmacology"}, {"key": "CR12", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1016/S0028-3908(02)00079-5", "volume": "43", "author": "A-M Linden", "year": "2002", "unstructured": "Linden A-M, Johnson BG, Peters SC, Shannon HE, Tian M, Wang Y, Yu JL, Koster A, Baez M, Schoepp DD (2002) Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor. Neuropharmacology 43:251?259", "journal-title": "Neuropharmacology"}, {"key": "CR13", "doi-asserted-by": "crossref", "first-page": "502", "DOI": "10.1038/sj.npp.1300321", "volume": "29", "author": "A-M Linden", "year": "2004", "unstructured": "Linden A-M, Greene SJ, Bergeron M, Schoepp DD (2004) Anxiolytic activity of the mGlu2/3 receptor agonist LY354740 is associated with the suppression of stress-induced c-Fos in the hippocampus and the increases in c-Fos induction in the several other stress-sensitive brain regions. Neuropsychopharmacology 29:502?513", "journal-title": "Neuropsychopharmacology"}, {"key": "CR14", "first-page": "180", "volume": "92", "author": "RG Lister", "year": "1987", "unstructured": "Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180?185", "journal-title": "Psychopharmacology"}, {"key": "CR15", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1021/jm9606756", "volume": "40", "author": "JA Monn", "year": "1997", "unstructured": "Monn JA, Valli MJ, Massey SM, Wright RA, Salhoff CR, Johnson BG, Howe T, Alt CA, Rhodes GA, Robey RL, Griffey KR, Tizzano JP, Kallman MJ, Helton DR, Schoepp DD (1997) Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J Med Chem 40:528?537", "journal-title": "J Med Chem"}, {"key": "CR16", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.1016/0306-4522(93)90485-X", "volume": "53", "author": "H Ohishi", "year": "1993", "unstructured": "Ohishi H, Shigemoto R, Nakanishi S, Mizuno N (1993a) Distribution of the messengers RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 53:1009?1018", "journal-title": "Neuroscience"}, {"key": "CR17", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1002/cne.903350209", "volume": "335", "author": "H Ohishi", "year": "1993", "unstructured": "Ohishi H, Shigemoto R, Nakanishi S, Mizuno N (1993b) Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol 335:252?266", "journal-title": "J Comp Neurol"}, {"key": "CR18", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1021/jm970498o", "volume": "41", "author": "P Ornstein", "year": "1998", "unstructured": "Ornstein P, Bleisch T, Arnold M, Kennedy J, Wright R, Johnson B, Tizzano J, Helton D, Kallman M, Schoepp D, Herin M (1998) 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability. J Med Chem 41:358?378", "journal-title": "J Med Chem"}, {"key": "CR19", "first-page": "12", "volume": "299", "author": "DD Schoepp", "year": "2001", "unstructured": "Schoepp DD (2001) Unveiling the function of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther 299:12?20", "journal-title": "J Pharmacol Exp Ther"}, {"key": "CR20", "doi-asserted-by": "crossref", "first-page": "1431", "DOI": "10.1016/S0028-3908(99)00092-1", "volume": "38", "author": "DD Schoepp", "year": "1999", "unstructured": "Schoepp DD, Jane DE, Monn JA (1999a) Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38:1431?1476", "journal-title": "Neuropharmacology"}, {"key": "CR21", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1111/j.1527-3458.1999.tb00082.x", "volume": "5", "author": "DD Schoepp", "year": "1999", "unstructured": "Schoepp DD, Monn JA, Marek GJ, Aghajanian G, Moghaddam B (1999b) LY354740: a systemically active mGlu2/3 receptor agonist. CNS Drug Rev 5:1?12", "journal-title": "CNS Drug Rev"}, {"key": "CR22", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1080/1025389031000146773", "volume": "6", "author": "DD Schoepp", "year": "2003", "unstructured": "Schoepp DD, Wright RA, Levine LR, Gaydos B, Potter WZ (2003) LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress. Stress 6:189?197", "journal-title": "Stress"}, {"key": "CR23", "doi-asserted-by": "crossref", "first-page": "1139", "DOI": "10.1016/S0028-3908(99)00215-4", "volume": "39", "author": "A Shekhar", "year": "2000", "unstructured": "Shekhar A, Keim SR (2000) LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats. Neuropharmacology 39:1139?1146", "journal-title": "Neuropharmacology"}, {"key": "CR24", "doi-asserted-by": "crossref", "first-page": "7503", "DOI": "10.1523/JNEUROSCI.17-19-07503.1997", "volume": "17", "author": "R Shigemoto", "year": "1997", "unstructured": "Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ, Neki A, Abe T, Nakanishi S, Mizuno N (1997) Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci 17:7503?7522", "journal-title": "J Neurosci"}, {"key": "CR25", "doi-asserted-by": "crossref", "first-page": "R1", "DOI": "10.1016/S0014-2999(00)00269-7", "volume": "397", "author": "W Spooren", "year": "2000", "unstructured": "Spooren W, Gasparini F, van der Putten H, Koller M, Nakanishi S, Kuhn R (2000) Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice. Eur J Pharmacol 397:R1?R2", "journal-title": "Eur J Pharmacol"}, {"key": "CR26", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/S0165-6147(00)01694-1", "volume": "22", "author": "W Spooren", "year": "2001", "unstructured": "Spooren W, Gasparini F, Salt T, Kuhn R (2001) Novel allosteric antagonists shed light on mlgu5 receptors in CNS disorders. Trends Pharmacol Sci 22:331?337", "journal-title": "Trends Pharmacol Sci"}, {"key": "CR27", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/S0014-2999(01)01562-X", "volume": "435", "author": "WPJM Spooren", "year": "2002", "unstructured": "Spooren WPJM, Schoeffter P, Gasparini F, Kuhn R, Gentsch C (2002) Pharmacological and endocrinological characterization of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol 435:161?170", "journal-title": "Eur J Pharmacol"}, {"key": "CR28", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1016/S0306-4522(01)00305-0", "volume": "106", "author": "Y Tamaru", "year": "2001", "unstructured": "Tamaru Y, Nomura S, Mizuno N, Shigemoto R (2001) Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience 106:481?503", "journal-title": "Neuroscience"}, {"key": "CR29", "doi-asserted-by": "crossref", "first-page": "94", "DOI": "10.1007/s002130100798", "volume": "158", "author": "E Tatarczynska", "year": "2001", "unstructured": "Tatarczynska E, Klodzinska A, Kroczka B, Chojnacka-Wojcik E, Pilc A (2001) The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology (Berl) 158:94?99", "journal-title": "Psychopharmacology (Berl)"}, {"key": "CR30", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1016/S0091-3057(02)00850-X", "volume": "73", "author": "JP Tizzano", "year": "2002", "unstructured": "Tizzano JP, Griffey KI, Schoepp DD (2002) The anxiolytic action of mGlu2/3 receptor agonist LY354740 in fear potentiated startle model in rats is independent of GABAergic modulation and mechanistically distinct from diazepam. Pharmacol Biochem Behav 73:367?374", "journal-title": "Pharmacol Biochem Behav"}, {"key": "CR31", "doi-asserted-by": "crossref", "first-page": "1075", "DOI": "10.1037/0735-7044.116.6.1075", "volume": "116", "author": "D Walker", "year": "2002", "unstructured": "Walker D, Rattiner L, Davis M (2002) Group II metabotropic glutamate receptors within the amygdala regulate fear as assessed with potentiated startle in rats. Behav Neurosci 116:1075?1083", "journal-title": "Behav Neurosci"}, {"key": "CR32", "doi-asserted-by": "crossref", "first-page": "645", "DOI": "10.1126/science.273.5275.645", "volume": "273", "author": "M Yokoi", "year": "1996", "unstructured": "Yokoi M, Kobayashi K, Manabe T, Takahashi T, Sakaguchi I, Katsuura G, Shigemoto R, Ohishi H, Nomura S, Nakamura K, Nakao K, Katsuki M, Nakanishi S (1996) Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science 273:645?647", "journal-title": "Science"}, {"key": "CR33", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/S0028-3908(02)00087-4", "volume": "43", "author": "J Zhai", "year": "2002", "unstructured": "Zhai J, Tian MT, Wang Y, Yu JL, Koster A, Baez M, Nisenbaum ES (2002) Modulation of lateral perforant path excitatory responses by metabotropic glutamate 8 (mGlu8) receptors. Neuropharmacology 43:223?230", "journal-title": "Neuropharmacology"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00213-004-2098-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00213-004-2098-x/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00213-004-2098-x", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T20:01:24Z", "timestamp": 1558641684000}, "score": 28.186886, "issued": {"date-parts": [[2004, 12, 24]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2005, 4]]}, "issue": "1"}, "alternative-id": ["2098"], "URL": "http://dx.doi.org/10.1007/s00213-004-2098-x", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:53:07Z", "timestamp": 1574124787961}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 5, 1]], "date-time": "1994-05-01T00:00:00Z", "timestamp": 767750400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cell"], "published-print": {"date-parts": [[1994, 5]]}, "DOI": "10.1016/0092-8674(94)90151-1", "type": "journal-article", "created": {"date-parts": [[2004, 5, 4]], "date-time": "2004-05-04T10:14:26Z", "timestamp": 1083665666000}, "page": "361-369", "source": "Crossref", "is-referenced-by-count": 255, "title": ["Developmentally regulated postsynaptic localization of a metabotropic glutamate receptor in rat rod bipolar cells"], "prefix": "10.1016", "volume": "77", "author": [{"given": "A", "family": "NOMURA", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Cell"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0092-8674(94)90151-1?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0092-8674(94)90151-1?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 9]], "date-time": "2019-02-09T20:23:10Z", "timestamp": 1549743790000}, "score": 27.433182, "issued": {"date-parts": [[1994, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1994, 5]]}, "issue": "3"}, "alternative-id": ["0092-8674(94)90151-1"], "URL": "http://dx.doi.org/10.1016/0092-8674(94)90151-1", "ISSN": ["0092-8674"], "issn-type": [{"value": "0092-8674", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}